LEO Pharma has signed a definitive agreement for the acquisition of Replay, which focuses on treating rare genetic dermatological conditions.
LEO Pharma to acquire gene therapy company Replay
LEO Pharma has signed a definitive agreement for the acquisition of Replay, which focuses on treating rare genetic dermatological conditions.
Physician burnout is declining, systems are finding new ways to recruit physicians without raising pay, but international physicians are in limbo amid visa renewal delays. There …
Our lungs have evolved to heal from damage, but some smokers will suffer irreversible effects It used to be thought that the lungs couldn’t regenerate,” says …
The technology identifies patterns in the pancreas that are invisible to the human eye
قدم "اليوم السابع" على مدار الساعات القليلة الماضية عددا من الموضوعات الخدمية التي تقدم نصائح طبية تهم كل أفراد الأسرة